Under pathological conditions, disruption of TFAM can lead to mtDNA mispackaging, a massive release of damaged mtDNA, and down-regulation of TFAM also reduces the stability of the mtDNA mimetic nuclear structure (West et al., 2015)
Discovery of the problem Every medicine starts with a problem
The discrepancy may reflect differences in concentration, exposure time, assay method, culture conditions, or peptide-batch characteristics, but it has not yet been resolved experimentally
This helps mitigate menopause-related symptoms like fatigue, bone loss, and skin thinning while enhancing muscle tone and sleep quality
Transdermal estradiol in menopausal women depresses interleukin-6 without affecting other markers of immune response